Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

64.08
+0.66001.04%
Post-market: 64.080.00000.00%18:57 EST
Volume:3.63M
Turnover:231.87M
Market Cap:12.31B
PE:23.90
High:64.25
Open:63.09
Low:62.55
Close:63.42
52wk High:73.51
52wk Low:50.76
Shares:192.11M
Float Shares:178.10M
Volume Ratio:1.44
T/O Rate:2.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.68
EPS(LYR):2.21
ROE:9.07%
ROA:6.15%
PB:2.03
PE(LYR):29.03

Loading ...

BioMarin Pharmaceutical Inc expected to post earnings of 62 cents a share - Earnings Preview

Reuters
·
17 hours ago

Amicus FY 2025 Pombiliti + Opfolda sales rose 57% to USD 34.97M

Reuters
·
18 hours ago

BioMarin Pharmaceutical (BMRN) Receives a Buy from Bernstein

TIPRANKS
·
Feb 19

BioMarin Pharmaceutical Inc. to announce fourth quarter and full-year financial results

Reuters
·
Feb 17

BioMarin Pharmaceutical (BMRN) Receives a Buy from Canaccord Genuity

TIPRANKS
·
Feb 13

BioMarin Closes $850 Million Senior Unsecured Notes Offering

Reuters
·
Feb 13

Biomarin Announces Closing of Private Offering of Senior Notes

THOMSON REUTERS
·
Feb 13

BioMarin Pharmaceutical (BMRN) Gets a Buy from Jefferies

TIPRANKS
·
Feb 12

BridgeBio's oral drug improves growth in children with dwarfism in late-stage study

Reuters
·
Feb 12

BRIEF-Biomarin Receives Health Canada Notice Of Compliance With Conditions For Voxzogo®, For Achondroplasia

Reuters
·
Feb 11

Biomarin Receives Health Canada Notice of Compliance With Conditions for Voxzogo®, for Achondroplasia

THOMSON REUTERS
·
Feb 11

BioMarin Pharmaceutical Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Feb 07

BioMarin price target lowered to $84 from $122 at Piper Sandler

TIPRANKS
·
Feb 06

U.S. RESEARCH ROUNDUP-Amazon, Estée Lauder, Ralph Lauren

Reuters
·
Feb 06

Biomarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility

THOMSON REUTERS
·
Jan 30

Biomarin Pharmaceutical Inc - Completes Syndication of $2 Bln Term Loan "B" Facility

THOMSON REUTERS
·
Jan 30

BioMarin Weighs Amicus Deal And Billions In New Debt Financing

Simply Wall St.
·
Jan 29

Biomarin Pharmaceutical Inc - Estimates $3.2 Bln in Total Revenues for 2025 - SEC Filing

THOMSON REUTERS
·
Jan 26

Biomarin Pharmaceutical Inc FY2025 REV View $3.18 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
Jan 26

BRIEF-BioMarin Announces Proposed Private Offering Of Senior Notes And Syndication Of New Senior Secured Term Loan Facility

Reuters
·
Jan 26